Value Research

NPS now allows investors to go up to 100% equity.

Before you get excited, there's a catch.

The new limit applies only to fresh investments in a new scheme. Existing balances remain unchanged. The scheme also comes with a 15-year vesting requirement, and the tax treatment of higher withdrawals is yet to be clarified.

Full story: https://vro.in/6k2n4k

Investors argue. Data settles it.

Everyone has an opinion on NPS versus mutual funds. But when you compare the actual returns, the differences are surprisingly small.

We looked at equity, corporate bonds and gilts to see how NPS stacks up against comparable mutual fund categories.

Swipe through to see who really comes out ahead.

Getting international exposure today feels a bit like finding an empty seat on a packed flight. ✈️🌍

A few options are still available while most international funds remain closed to fresh inflows.

See which funds are still accepting SIPs, where they invest, and why access has become so limited.

Full story: vro.in/s228698

Inox India's exports have nearly quadrupled in four years. But that's only half the story.

From rockets to LNG terminals and grid-scale energy storage, here's why investors are watching its global ambitions closely.

Read the full analysis: https://vro.in/fe3vv7

After 20 years in the markets, what lessons still matter?

Gaurik Shah, Fund Manager, Mirae Asset India, shares the principles that have guided him through market cycles.

Watch now: https://www.youtube.com/watch?v=rlLew2tW7Y8

If mutual funds had a favourite mid-cap list, this would be it.

These are the stocks attracting the highest collective investments across active mutual fund portfolios.

Which name were you expecting to see? Which one caught you off guard?

Comment below👇

All index funds track the same index.

So why don't they deliver the same returns?

Most investors compare expense ratios and stop there. But factors like tracking difference, tracking error, AUM and fund management quality can quietly impact your long-term returns.

In this episode of The Index Investor, Devender Goswami , Founder, of BluRockWealth breaks down what actually separates one index fund from another, and whether you should choose an ETF or an index fund.

Plus: a simple 5-point checklist every passive investor should know.

🎥 Full video: https://www.youtube.com/watch?v=UJG-Ltl7fpw&authuser=0

The June edition of Wealth Insight is out — and this one is built around a single idea:
the market is getting something wrong in almost every story we cover this month.

Whether you're tracking quality stocks, sorting out your home loan taxes, or trying
to understand what AI really means for your IT holdings — this edition has something
directly useful for you.

Here's what's inside:

🏆 10 companies going from good to great
A clear framework for spotting that shift early — and 10 names where the numbers
suggest it may already be happening.

💊 Where does the money actually go in pharma?
India makes medicines for the world. But most investors can't explain where the profit
sits in the supply chain. Our Sector Playbook traces it clearly.

🏦 PSU banks — is the discount finally closing?
SBI, Bank of Baroda, Canara Bank — clean books, restored profits, solid asset quality.
Yet still trading cheaper than private peers. We look at whether that gap is rational
or just stubborn.

🧪 Clean Science — global leader, stock still below peak
Zero debt. Market leadership in specialty chemicals. Industry-leading margins.
The stock is still well below its highs. What is the market missing — or what does it know?

🏠 Every home loan tax benefit you're entitled to
Most homebuyers miss deductions they fully qualify for. Section 24B, 80C, HRA, capital
gains relief — all in one practical guide.

🎙️ Why this HDFC fund manager is avoiding large-cap pharma
Nikhil Mathur of HDFC AMC explains why he thinks mid and small-cap pharma will grow
faster — and where he's finding value right now.

💻 Is the Indian IT hiring model broken?
For decades, IT companies grew by adding engineers. AI is changing what software
work costs — and who does it. What does that mean for TCS, Infosys, Wipro investors?

Independent research. No fund house influence.
₹150 at your nearest newsstand. Or subscribe online with this link👇
https://tinyurl.com/2vyhmcdc